| Year |
Citation |
Score |
| 2023 |
Li G, Toschi N, Devanarayan V, Batrla R, Boccato T, Cho M, Ferrante M, Frech F, Galvin JE, Henley D, Mattke S, De Santi S, Hampel H. The age-specific comorbidity burden of mild cognitive impairment: a US claims database study. Alzheimer's Research & Therapy. 15: 211. PMID 38057937 DOI: 10.1186/s13195-023-01358-8 |
0.314 |
|
| 2023 |
Jain L, Khrestian M, Formica S, Tuason ED, Pillai JA, Rao S, Oguh O, Lippa CF, Lopez OL, Berman SB, Tsuang DW, Zabetian CP, Irwin DJ, Galasko DR, Litvan I, ... ... Galvin JE, et al. ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37740924 DOI: 10.1002/alz.13398 |
0.319 |
|
| 2023 |
Tolea MI, Ezzeddine R, Camacho S, Galvin JE. Emerging drugs for dementia with Lewy Bodies: a review of Phase II & III trials. Expert Opinion On Emerging Drugs. 1-14. PMID 37531299 DOI: 10.1080/14728214.2023.2244425 |
0.357 |
|
| 2023 |
Mascarenhas Fonseca L, Sage Chaytor N, Olufadi Y, Buchwald D, Galvin JE, Schmitter-Edgecombe M, Suchy-Dicey A. Intraindividual Cognitive Variability and Magnetic Resonance Imaging in Aging American Indians: Data from the Strong Heart Study. Journal of Alzheimer's Disease : Jad. PMID 36641671 DOI: 10.3233/JAD-220825 |
0.304 |
|
| 2023 |
Kleiman MJ, Ariko T, Galvin JE. Hierarchical Two-Stage Cost-Sensitive Clinical Decision Support System for Screening Prodromal Alzheimer's Disease and Related Dementias. Journal of Alzheimer's Disease : Jad. 91: 895-909. PMID 36502329 DOI: 10.3233/JAD-220891 |
0.311 |
|
| 2022 |
Joshi MS, Galvin JE. Cognitive Resilience in Brain Health and Dementia Research. Journal of Alzheimer's Disease : Jad. PMID 36093713 DOI: 10.3233/JAD-220755 |
0.322 |
|
| 2022 |
Avey JP, Schaefer KR, Noonan CJ, Muller CJ, Mosley M, Galvin JE. Patterns of Healthcare Use and Mortality After Alzheimer's Disease or Related Dementia Diagnosis Among Alaska Native Patients: Results of a Cluster Analysis in a Tribal Healthcare Setting. Journal of Alzheimer's Disease Reports. 6: 401-410. PMID 36072365 DOI: 10.3233/ADR-210062 |
0.307 |
|
| 2022 |
Pang M, Zhu L, Gabelle A, Gafson AR, Platt RW, Galvin JE, Krolak-Salmon P, Rubino I, de Moor C, Belachew S, Shen C. Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta-analysis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36043526 DOI: 10.1002/alz.12768 |
0.33 |
|
| 2022 |
Seifallahi M, Mehraban AH, Galvin JE, Ghoraani B. Alzheimer's Disease Detection Using Comprehensive Analysis of Timed Up and Go Test via Kinect V.2 Camera and Machine Learning. Ieee Transactions On Neural Systems and Rehabilitation Engineering : a Publication of the Ieee Engineering in Medicine and Biology Society. 30: 1589-1600. PMID 35675251 DOI: 10.1109/TNSRE.2022.3181252 |
0.309 |
|
| 2022 |
Scott GD, Arnold MR, Beach TG, Gibbons CH, Kanthasamy AG, Lebovitz RM, Lemstra AW, Shaw LM, Teunissen CE, Zetterberg H, Taylor AS, Graham TC, Boeve BF, Gomperts SN, Graff-Radford NR, ... ... Galvin JE, et al. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium. Frontiers in Neurology. 12: 805135. PMID 35173668 DOI: 10.3389/fneur.2021.805135 |
0.31 |
|
| 2021 |
Galvin JE, Kleiman MJ, Chrisphonte S, Cohen I, Disla S, Galvin CB, Greenfield KK, Moore C, Rawn S, Riccio ML, Rosenfeld A, Simon J, Walker M, Tolea MI. The Resilience Index: A Quantifiable Measure of Brain Health and Risk of Cognitive Impairment and Dementia. Journal of Alzheimer's Disease : Jad. PMID 34744081 DOI: 10.3233/JAD-215077 |
0.342 |
|
| 2021 |
Galvin JE, Kleiman MJ, Walker M. Using Optical Coherence Tomography to Screen for Cognitive Impairment and Dementia. Journal of Alzheimer's Disease : Jad. PMID 34569948 DOI: 10.3233/JAD-210328 |
0.301 |
|
| 2021 |
Besser L, Chang LC, Evenson KR, Hirsch J, Michael Y, Galvin JE, Rapp SR, Fitzpatrick AL, Heckbert SR, Kaufman JD, Hughes TM. Associations Between Neighborhood Park Access and Longitudinal Change in Cognition in Older Adults: The Multi-Ethnic Study of Atherosclerosis. Journal of Alzheimer's Disease : Jad. PMID 34024841 DOI: 10.3233/JAD-210370 |
0.311 |
|
| 2021 |
Galvin JE, Chrisphonte S, Cohen I, Greenfield KK, Kleiman MJ, Moore C, Riccio ML, Rosenfeld A, Shkolnik N, Walker M, Chang LC, Tolea MI. Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33793069 DOI: 10.1002/alz.12334 |
0.381 |
|
| 2021 |
Maserejian N, Krzywy H, Eaton S, Galvin JE. Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33656251 DOI: 10.1002/alz.12280 |
0.37 |
|
| 2021 |
Rigby T, Johnson DK, Taylor A, Galvin JE. Comparison of the Caregiving Experience of Grief, Burden, and Quality of Life in Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease Dementia. Journal of Alzheimer's Disease : Jad. PMID 33554912 DOI: 10.3233/JAD-201326 |
0.367 |
|
| 2020 |
Ghoraani B, Boettcher LN, Hssayeni MD, Rosenfeld A, Tolea MI, Galvin JE. Detection of Mild Cognitive Impairment and Alzheimer's Disease using Dual-task Gait Assessments and Machine Learning. Biomedical Signal Processing and Control. 64. PMID 33123214 DOI: 10.1016/j.bspc.2020.102249 |
0.318 |
|
| 2020 |
Galvin JE, Tolea MI, Chrisphonte S. Using a patient-reported outcome to improve detection of cognitive impairment and dementia: The patient version of the Quick Dementia Rating System (QDRS). Plos One. 15: e0240422. PMID 33057404 DOI: 10.1371/journal.pone.0240422 |
0.303 |
|
| 2020 |
Wiese LK, Williams CL, Hain D, Newman D, Houston CP, Kaack C, Galvin JE. Detecting dementia among older, ethnically diverse residents of rural subsidized housing. Geriatric Nursing (New York, N.Y.). PMID 33039199 DOI: 10.1016/j.gerinurse.2020.09.005 |
0.311 |
|
| 2020 |
Galvin JE, Tolea MI, Chrisphonte S. What older adults do with the results of dementia screening programs. Plos One. 15: e0235534. PMID 32609745 DOI: 10.1371/journal.pone.0235534 |
0.325 |
|
| 2020 |
Bristol AA, Convery KA, Sote V, Schneider CE, Lin SY, Fletcher J, Rupper R, Wahlen GE, Galvin JE, Brody AA. Protocol for an embedded pragmatic clinical trial to test the effectiveness of Aliviado Dementia Care in improving quality of life for persons living with dementia and their informal caregivers. Contemporary Clinical Trials. 106005. PMID 32320844 DOI: 10.1016/J.Cct.2020.106005 |
0.303 |
|
| 2020 |
McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, ... Galvin JE, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. PMID 32241955 DOI: 10.1212/Wnl.0000000000009323 |
0.337 |
|
| 2020 |
Wiese LK, Williams I, Williams CL, Galvin JE. Discerning rural Appalachian stakeholder attitudes toward memory screening. Aging & Mental Health. 1-10. PMID 32081028 DOI: 10.1080/13607863.2020.1725739 |
0.406 |
|
| 2020 |
Park J, Howard H, Tolea MI, Galvin JE. Perceived Benefits of Using Nonpharmacological Interventions in Older Adults With Alzheimer's Disease or Dementia With Lewy Bodies. Journal of Gerontological Nursing. 46: 37-46. PMID 31895960 DOI: 10.3928/00989134-20191217-01 |
0.405 |
|
| 2019 |
Besser L, Galvin JE, Rodriguez D, Seeman T, Kukull W, Rapp SR, Smith J. Associations between neighborhood built environment and cognition vary by apolipoprotein E genotype: Multi-Ethnic Study of Atherosclerosis. Health & Place. 60: 102188. PMID 31797769 DOI: 10.1016/J.Healthplace.2019.102188 |
0.389 |
|
| 2019 |
Park J, Tolea MI, Sherman D, Rosenfeld A, Arcay V, Lopes Y, Galvin JE. Feasibility of Conducting Nonpharmacological Interventions to Manage Dementia Symptoms in Community-Dwelling Older Adults: A Cluster Randomized Controlled Trial. American Journal of Alzheimer's Disease and Other Dementias. 1533317519872635. PMID 31533443 DOI: 10.1177/1533317519872635 |
0.301 |
|
| 2019 |
Rigby T, Ashwill RT, Johnson DK, Galvin JE. Differences in the Experience of Caregiving Between Spouse and Adult Child Caregivers in Dementia With Lewy Bodies. Innovation in Aging. 3: igz027. PMID 31528714 DOI: 10.1093/Geroni/Igz027 |
0.381 |
|
| 2019 |
Armstrong MJ, Alliance S, Taylor A, Corsentino P, Galvin JE. End-of-life experiences in dementia with Lewy bodies: Qualitative interviews with former caregivers. Plos One. 14: e0217039. PMID 31145749 DOI: 10.1371/Journal.Pone.0217039 |
0.42 |
|
| 2019 |
Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, et al. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimer's Research & Therapy. 11: 23. PMID 30867052 DOI: 10.1186/S13195-019-0476-1 |
0.415 |
|
| 2019 |
Besser LM, Galvin JE. Perceived burden among caregivers of patients with frontotemporal degeneration in the United States. International Psychogeriatrics. 31: 1191-1201. PMID 30398132 DOI: 10.1017/S104161021800159X |
0.366 |
|
| 2019 |
Tolea MI, Park J, Galvin J. Mindfulness And Cognitive Function In Patients With Cognitive Impairment Innovation in Aging. 3. DOI: 10.1093/Geroni/Igz038.2444 |
0.335 |
|
| 2019 |
Park J, Tolea MI, Arcay V, Lopes Y, Galvin JE. Self-efficacy and social support for psychological well-being of family caregivers of care recipients with dementia with Lewy bodies, Parkinson’s disease dementia, or Alzheimer’s disease Social Work in Mental Health. 17: 253-278. DOI: 10.1080/15332985.2018.1526756 |
0.429 |
|
| 2019 |
Wiese LK, Williams CL, Hain DD, Newman D, Galvin JE. F4-06-04: Detecting Dementia In Older, Ethnically Diverse Residents In Rural Subsidized Housing Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4736 |
0.315 |
|
| 2018 |
Hodes JF, Oakley CI, O'Keefe JH, Lu P, Galvin JE, Saif N, Bellara S, Rahman A, Kaufman Y, Hristov H, Rajji TK, Fosnacht Morgan AM, Patel S, Merrill DA, Kaiser S, et al. Alzheimer's "Prevention" vs. "Risk Reduction": Transcending Semantics for Clinical Practice. Frontiers in Neurology. 9: 1179. PMID 30719021 DOI: 10.3389/Fneur.2018.01179 |
0.41 |
|
| 2018 |
Kirk Wiese L, Galvin JE, Williams CL. Rural stakeholder perceptions about cognitive screening. Aging & Mental Health. 1-13. PMID 30588841 DOI: 10.1080/13607863.2018.1525607 |
0.311 |
|
| 2018 |
Boltz M, Kuzmik A, Resnick B, Trotta R, Mogle J, BeLue R, Leslie D, Galvin JE. Reducing disability via a family centered intervention for acutely ill persons with Alzheimer's disease and related dementias: protocol of a cluster-randomized controlled trial (Fam-FFC study). Trials. 19: 496. PMID 30223870 DOI: 10.1186/S13063-018-2875-1 |
0.434 |
|
| 2018 |
Galvin JE. Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia. Current Geriatrics Reports. 7: 19-25. PMID 29963365 DOI: 10.1007/S13670-018-0236-2 |
0.402 |
|
| 2018 |
Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, Dobkin RD, Ellis T, Galvin JE, Marras C, Edwards J, Fields J, Golden R, Karlawish J, Levin B, Shulman L, Smith G, et al. Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. Npj Parkinson's Disease. 4: 19. PMID 29951580 DOI: 10.1038/S41531-018-0055-3 |
0.361 |
|
| 2018 |
Tolea MI, Galvin JE. The genetics of dementia with Lewy bodies Handbook of Clinical Neurology. 148: 431-440. PMID 29478592 DOI: 10.1016/B978-0-444-64076-5.00028-4 |
0.363 |
|
| 2018 |
Galvin JE. Advancing personalized treatment of Alzheimer's disease: a call for the N-of-1 trial design Future Neurology. 13: 151-160. DOI: 10.2217/Fnl-2018-0004 |
0.331 |
|
| 2018 |
Tolea M, Galvin J. Caregiver Relationship To Dementia Patient: Impact On Disease Progression And Caregiver Psychological Well-Being. Innovation in Aging. 2: 852-852. DOI: 10.1093/Geroni/Igy023.3175 |
0.405 |
|
| 2018 |
Wiese LK, Williams CL, Galvin JE, Hain DD. P1-584: Cognitive Screening In Rural Florida Subsidized Housing Units Among Ethnically Diverse Older Adults Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.596 |
0.306 |
|
| 2018 |
Hamed M, Schraml F, Wilson J, Galvin JE, Sabbagh MN. P1-392: Occipital And Cingulate Hypometabolism Are Significantly Under-Reported On 18-Fluorodeoxyglucose Positron Emission Tomography Scans Of Patients With Lewy Body Dementia Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.400 |
0.312 |
|
| 2018 |
Boeve BF, Armstrong M, Galvin JE, Goldman J, Irwin DJ, Kaufer D, Leverenz JB, Lunde AM, McKeith IG, Paulson HL, Siderowf AD, Barrett MJ, Kimiko D, Duda J, Galasko DR, et al. O5-03-04: The Lewy Body Dementia Association Research Centers Of Excellence Program: Toward Optimizing Clinical Care And Clinical Trial Infrastructure Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.3010 |
0.315 |
|
| 2018 |
Rigby T, Johnson DK, Galvin JE. P3-522: Differences In Caregiver Grief And Burden Among Dementia With Lewy Bodies, Dementia Of The Alzheimer'S Type, And Dementia Associated With Parkinson'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1887 |
0.464 |
|
| 2018 |
Rigby T, Ashwill RT, Galvin JE, Johnson DK. P2-559: Differences In The Experience Of Caregiving Between Spouse And Adult Child Caregivers In Dementia With Lewy Bodies Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1254 |
0.363 |
|
| 2017 |
Galvin JE, Howard DH, Denny SS, Dickinson S, Tatton N. The social and economic burden of frontotemporal degeneration. Neurology. PMID 28978658 DOI: 10.1212/Wnl.0000000000004614 |
0.376 |
|
| 2017 |
Berman SE, Koscik RL, Clark LR, Mueller KD, Bluder L, Galvin JE, Johnson SC. Use of the Quick Dementia Rating System (QDRS) as an Initial Screening Measure in a Longitudinal Cohort at Risk for Alzheimer's Disease. Jad Reports. 1: 9-13. PMID 28819654 DOI: 10.3233/ADR-170004 |
0.312 |
|
| 2017 |
Galvin JE. Prevention of Alzheimer's Disease: Lessons Learned and Applied Journal of the American Geriatrics Society. 65: 2128-2133. PMID 28766695 DOI: 10.1111/Jgs.14997 |
0.413 |
|
| 2017 |
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. PMID 28592453 DOI: 10.1212/Wnl.0000000000004058 |
0.402 |
|
| 2017 |
Read KB, LaPolla FW, Tolea MI, Galvin JE, Surkis A. Improving data collection, documentation, and workflow in a dementia screening study. Journal of the Medical Library Association : Jmla. 105: 160-166. PMID 28377680 DOI: 10.5195/Jmla.2017.221 |
0.313 |
|
| 2016 |
Ryu HJ, Kim M, Moon Y, Choi Y, Han J, Galvin JE, Han SH. Validation of the Korean Version of the Lewy Body Composite Risk Score (K-LBCRS). Journal of Alzheimer's Disease : Jad. PMID 27834773 DOI: 10.3233/Jad-160463 |
0.387 |
|
| 2016 |
Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, et al. Arguing against the proposed definition changes of PD. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27492190 DOI: 10.1002/Mds.26721 |
0.384 |
|
| 2016 |
Brody AA, Guan C, Cortes T, Galvin JE. Development and testing of the Dementia Symptom Management at Home (DSM-H) program: An interprofessional home health care intervention to improve the quality of life for persons with dementia and their caregivers. Geriatric Nursing (New York, N.Y.). PMID 26922312 DOI: 10.1016/J.Gerinurse.2016.01.002 |
0.334 |
|
| 2016 |
Tolea MI, Galvin JE. The Relationship Between Mobility Dysfunction Staging and Global Cognitive Performance. Alzheimer Disease and Associated Disorders. PMID 26840544 DOI: 10.1097/Wad.0000000000000136 |
0.307 |
|
| 2016 |
Kelleher M, Tolea MI, Galvin JE. Anosognosia increases caregiver burden in mild cognitive impairment. International Journal of Geriatric Psychiatry. 31: 799-808. PMID 26643996 DOI: 10.1002/Gps.4394 |
0.395 |
|
| 2016 |
Son A, Biagioni M, Agarwal S, Li Y, Brys M, Rocco AD, Galvin J. Structural changes in basal ganglia-thalamocortical circuits in Parkinson's disease with cognitive impairment Parkinsonism & Related Disorders. 22. DOI: 10.1016/J.Parkreldis.2015.10.371 |
0.366 |
|
| 2016 |
Galvin JE, Tolea MI, Chrisphonte S, Saravia K. Obstructive Airway Disease And The Risk Of Cognitive Impairment In A Multicultural Community Of Older Adults Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.2248 |
0.338 |
|
| 2015 |
Galvin JE. IMPROVING THE CLINICAL DETECTION OF LEWY BODY DEMENTIA WITH THE LEWY BODY COMPOSITE RISK SCORE. Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 316-324. PMID 26405688 DOI: 10.1016/J.Dadm.2015.05.004 |
0.375 |
|
| 2015 |
Galvin JE. THE QUICK DEMENTIA RATING SYSTEM (QDRS): A RAPID DEMENTIA STAGING TOOL. Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 249-259. PMID 26140284 DOI: 10.1016/J.Dadm.2015.03.003 |
0.385 |
|
| 2015 |
Boltz M, Chippendale T, Resnick B, Galvin JE. Testing family-centered, function-focused care in hospitalized persons with dementia. Neurodegenerative Disease Management. 5: 203-15. PMID 26107319 DOI: 10.2217/Nmt.15.10 |
0.34 |
|
| 2015 |
Tolea MI, Morris JC, Galvin JE. Trajectory of Mobility Decline by Type of Dementia. Alzheimer Disease and Associated Disorders. PMID 25886717 DOI: 10.1097/Wad.0000000000000091 |
0.417 |
|
| 2015 |
Tolea MI, Galvin JE. Sarcopenia and impairment in cognitive and physical performance. Clinical Interventions in Aging. 10: 663-71. PMID 25878493 DOI: 10.2147/Cia.S76275 |
0.348 |
|
| 2015 |
Tolea MI, Morris JC, Galvin JE. Longitudinal associations between physical and cognitive performance among community-dwelling older adults. Plos One. 10: e0122878. PMID 25875165 DOI: 10.1371/Journal.Pone.0122878 |
0.371 |
|
| 2015 |
Galvin JE. Comment: Too much of a good thing may still be good for your brain. Neurology. 84: 1859. PMID 25854870 DOI: 10.1212/Wnl.0000000000001547 |
0.415 |
|
| 2015 |
Johnson DK, Langford Z, Garnier-Villarreal M, Morris JC, Galvin JE. Onset of Mild Cognitive Impairment in Parkinson Disease. Alzheimer Disease and Associated Disorders. PMID 25850732 DOI: 10.1097/Wad.0000000000000088 |
0.354 |
|
| 2015 |
Molinuevo JL, Frölich L, Grossberg GT, Galvin JE, Cummings JL, Krahnke T, Strohmaier C. Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch. Alzheimer's Research & Therapy. 7: 9. PMID 25755685 DOI: 10.1186/S13195-014-0088-8 |
0.306 |
|
| 2015 |
Alva G, Cummings JL, Galvin JE, Meng X, Velting DM. Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease. International Journal of Clinical Practice. 69: 518-30. PMID 25684069 DOI: 10.1111/Ijcp.12621 |
0.332 |
|
| 2015 |
Boltz M, Chippendale T, Resnick B, Galvin JE. Anxiety in Family Caregivers of Hospitalized Persons With Dementia: Contributing Factors and Responses. Alzheimer Disease and Associated Disorders. PMID 25635341 DOI: 10.1097/Wad.0000000000000072 |
0.347 |
|
| 2015 |
Shim YS, Yang DW, Roe CM, Coats MA, Benzinger TL, Xiong C, Galvin JE, Cairns NJ, Morris JC. Pathological correlates of white matter hyperintensities on magnetic resonance imaging. Dementia and Geriatric Cognitive Disorders. 39: 92-104. PMID 25401390 DOI: 10.1159/000366411 |
0.345 |
|
| 2015 |
Hurth K, Tarawneh R, Ghoshal N, Benzinger TL, Clifford DB, Geschwind M, Morris JC, Galvin JE, Schmidt RE, Cairns NJ. Whipple's disease masquerades as dementia with Lewy bodies. Alzheimer Disease and Associated Disorders. 29: 85-9. PMID 23995819 DOI: 10.1097/Wad.0B013E3182A715Da |
0.41 |
|
| 2015 |
Galvin JE. Perception differences in health status, medical care access, and Alzheimer disease between caucasians and african americans Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.281 |
0.313 |
|
| 2015 |
Tashish C, Galvin JE. The role of isolation in dementia caregiver grief Alzheimers & Dementia. 11: 601. DOI: 10.1016/J.Jalz.2015.06.828 |
0.371 |
|
| 2015 |
Ashwill R, Mulhall S, Johnson DK, Galvin JE. Caregiving experience for people with lewy body dementia: Spouse versus adult child Alzheimers & Dementia. 11: 601. DOI: 10.1016/J.Jalz.2015.06.827 |
0.367 |
|
| 2015 |
Rigby T, Ashwill R, Mulhall S, Johnson DK, Galvin JE. Caregiver experience of grief and burden is similar across Alzheimer’s, parkinson’s, and lewy body dementia types Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.797 |
0.388 |
|
| 2015 |
Tolea MI, Galvin JE, Morris JC. Interrelationships between cognitive and physical impairment Alzheimers & Dementia. 11: 830. DOI: 10.1016/J.Jalz.2015.06.1842 |
0.332 |
|
| 2015 |
Kelleher M, Galvin JE, McCue RE, Cerbone B. Anosognosia Increases Caregiver Burden in Mild Cognitive Impairment (MCI) The American Journal of Geriatric Psychiatry. 23: S142. DOI: 10.1016/J.Jagp.2014.12.147 |
0.398 |
|
| 2014 |
Micca JL, Galvin JE, Velting DM, Meng X. Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease. Sage Open Medicine. 2: 2050312114561569. PMID 26770753 DOI: 10.1177/2050312114561569 |
0.325 |
|
| 2014 |
Galvin JE, Valois L, Zweig Y. Collaborative transdisciplinary team approach for dementia care. Neurodegenerative Disease Management. 4: 455-69. PMID 25531688 DOI: 10.2217/Nmt.14.47 |
0.371 |
|
| 2014 |
Boltz M, Resnick B, Chippendale T, Galvin J. Testing a family-centered intervention to promote functional and cognitive recovery in hospitalized older adults. Journal of the American Geriatrics Society. 62: 2398-407. PMID 25481973 DOI: 10.1111/Jgs.13139 |
0.313 |
|
| 2014 |
Zweig YR, Galvin JE. Lewy body dementia: the impact on patients and caregivers. Alzheimer's Research & Therapy. 6: 21. PMID 25031635 DOI: 10.1186/Alzrt251 |
0.398 |
|
| 2014 |
Yusupov A, Galvin JE. Vocalization in dementia: a case report and review of the literature. Case Reports in Neurology. 6: 126-33. PMID 24926262 DOI: 10.1159/000362159 |
0.378 |
|
| 2014 |
Goldman JG, Williams-Gray C, Barker RA, Duda JE, Galvin JE. The spectrum of cognitive impairment in Lewy body diseases. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 608-21. PMID 24757110 DOI: 10.1002/Mds.25866 |
0.435 |
|
| 2014 |
Galvin JE, Tolea MI, George N, Wingbermuehle C. Public-private partnerships improve health outcomes in individuals with early stage Alzheimer's disease. Clinical Interventions in Aging. 9: 621-30. PMID 24748780 DOI: 10.2147/Cia.S60838 |
0.333 |
|
| 2014 |
Grill JD, Galvin JE. Facilitating Alzheimer disease research recruitment. Alzheimer Disease and Associated Disorders. 28: 1-8. PMID 24322484 DOI: 10.1097/Wad.0000000000000016 |
0.348 |
|
| 2014 |
Razavi M, Tolea MI, Margrett J, Martin P, Oakland A, Tscholl DW, Ghods S, Mina M, Galvin JE. Comparison of 2 informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE. Alzheimer Disease and Associated Disorders. 28: 156-61. PMID 24113559 DOI: 10.1097/Wad.0000000000000008 |
0.427 |
|
| 2014 |
Molinuevo JL, Cummings J, Frolich L, Galvin JE, Krahnke T, Strohmaier C. Up-Titration To High-Dose 13.3 Mg/24 H Rivastigmine Transdermal Patch May Provide Greater Benefit To Alzheimer'S Disease Patients Compared To Concomitant Use Of 9.5 Mg/24 H Patch And Memantine: Results From The Optima Study Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1702 |
0.303 |
|
| 2014 |
Galvin JE, Tolea M. Staging Of Physical Functional Impairment As A Correlate Of Global Cognition Alzheimers & Dementia. 10: 688. DOI: 10.1016/J.Jalz.2014.05.1251 |
0.349 |
|
| 2013 |
Karantzoulis S, Galvin JE. UPDATE ON DEMENTIA WITH LEWY BODIES. Current Translational Geriatrics and Experimental Gerontology Reports. 2: 196-204. PMID 25379359 DOI: 10.1007/S13670-013-0053-6 |
0.478 |
|
| 2013 |
Tolea MI, Galvin JE. Current guidelines for dementia screening: shortcomings and recommended changes. Neurodegenerative Disease Management. 3: 565-573. PMID 25152772 DOI: 10.2217/Nmt.13.58 |
0.391 |
|
| 2013 |
Brody AA, Galvin JE. A review of interprofessional dissemination and education interventions for recognizing and managing dementia. Gerontology & Geriatrics Education. 34: 225-56. PMID 23879387 DOI: 10.1080/02701960.2013.801342 |
0.368 |
|
| 2013 |
Wilkins CH, Roe CM, Morris JC, Galvin JE. Mild physical impairment predicts future diagnosis of dementia of the Alzheimer's type. Journal of the American Geriatrics Society. 61: 1055-9. PMID 23647233 DOI: 10.1111/Jgs.12255 |
0.439 |
|
| 2013 |
Thaipisuttikul P, Lobach I, Zweig Y, Gurnani A, Galvin JE. Capgras syndrome in Dementia with Lewy Bodies. International Psychogeriatrics / Ipa. 25: 843-9. PMID 23211760 DOI: 10.1017/S1041610212002189 |
0.351 |
|
| 2013 |
Carnero Pardo C, de la Vega Cotarelo R, López Alcalde S, Martos Aparicio C, VÃlchez Carrillo R, Mora Gavilán E, Galvin JE. Assessing the diagnostic accuracy (DA) of the Spanish version of the informant-based AD8 questionnaire. Neurologãa (Barcelona, Spain). 28: 88-94. PMID 22652137 DOI: 10.1016/J.Nrleng.2012.03.013 |
0.327 |
|
| 2013 |
Raveis V, Bear-Lehman J, Galvin JE, Lanyi V, Carrero M, Tepfer S, Karus D. Peer-Reviewed Abstract: Early Intervention Falls Prevention Program for Community-Dwelling Elderly with Dementia. Gerontologist. DOI: 10.1093/Geront/Gnt151 |
0.306 |
|
| 2013 |
Molinuevo JL, Cummings J, Frölich L, Galvin J, Krahnke T, Strohmaier C. High-dose 13.3 mg/24 h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use Journal of the Neurological Sciences. 333. DOI: 10.1016/J.Jns.2013.07.1280 |
0.316 |
|
| 2013 |
Molinuevo JL, Grossberg G, Frölich L, Galvin J, Krahnke T, Strohmaier C. Predictors of response to the 13.3 and 9.5 mg/24 h rivastigmine patch: The optimizing /INS;transdermal exelon in mild-to-moderate Alzheimer's disease (optima) study Journal of the Neurological Sciences. 333. DOI: 10.1016/J.Jns.2013.07.1243 |
0.337 |
|
| 2013 |
Molinuevo JL, Grossberg G, Frölich L, Galvin J, Krahnke T, Strohmaier C. Incidence and predictors of response to the 13.3 (15 cm2) and 9.5 mg/24h (10 cm2) rivastigmine patch in the OPtimising Transdermal Exelon In Mild-to-moderate Alzheimer's disease (OPTIMA) study Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1349 |
0.326 |
|
| 2013 |
Galvin J, Tolea M, George N, Wingbermuele C, Bryer D, Neidens M, Cloud K, Coen J, Bonham J, King A, McKie M, Meachum-Cain G. Project Learn MORE: Expanding service usage of individuals with early-stage Alzheimer's disease Alzheimers & Dementia. 9: 615. DOI: 10.1016/J.Jalz.2013.05.1241 |
0.381 |
|
| 2013 |
Galvin J. Multicultural family detection of dementia Alzheimers & Dementia. 9: 515. DOI: 10.1016/J.Jalz.2013.04.230 |
0.339 |
|
| 2013 |
Galvin J. The importance of family and caregiver in the care and management of people with Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.012 |
0.37 |
|
| 2012 |
Rowe MA, Greenblum CA, Boltz M, Galvin JE. Missing drivers with dementia: antecedents and recovery. Journal of the American Geriatrics Society. 60: 2063-9. PMID 23134069 DOI: 10.1111/J.1532-5415.2012.04159.X |
0.406 |
|
| 2012 |
Galvin JE. OPTIMIZING DIAGNOSIS AND MANANGEMENT IN MILD-TO-MODERATE ALZHEIMER'S DISEASE. Neurodegenerative Disease Management. 2: 291-304. PMID 22973426 DOI: 10.2217/Nmt.12.21 |
0.422 |
|
| 2012 |
Monahan PO, Boustani MA, Alder C, Galvin JE, Perkins AJ, Healey P, Chehresa A, Shepard P, Bubp C, Frame A, Callahan C. Practical clinical tool to monitor dementia symptoms: the HABC-Monitor. Clinical Interventions in Aging. 7: 143-57. PMID 22791987 DOI: 10.2147/Cia.S30663 |
0.405 |
|
| 2012 |
Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. Journal of the American Board of Family Medicine : Jabfm. 25: 367-82. PMID 22570400 DOI: 10.3122/Jabfm.2012.03.100181 |
0.444 |
|
| 2012 |
Sadowsky CH, Galvin JE. Guidelines for the management of cognitive and behavioral problems in dementia. Journal of the American Board of Family Medicine : Jabfm. 25: 350-66. PMID 22570399 DOI: 10.3122/Jabfm.2012.03.100183 |
0.407 |
|
| 2012 |
Glodzik L, Galvin J, Pirraglia E, de Leon M. Ordering of Alzheimer disease biomarkers. Archives of Neurology. 69: 414; author reply 41. PMID 22410455 DOI: 10.1001/Archneurol.2011.2906 |
0.367 |
|
| 2012 |
Galvin JE, Meuser TM, Morris JC. Improving physician awareness of Alzheimer disease and enhancing recruitment: the Clinician Partners Program. Alzheimer Disease and Associated Disorders. 26: 61-7. PMID 21399484 DOI: 10.1016/J.Jalz.2011.05.432 |
0.397 |
|
| 2012 |
Galvin JE, Morris JC. Reply: The impact of dementia prevalence on the utility of the AD8 Brain. 135. DOI: 10.1093/Brain/Awr136 |
0.38 |
|
| 2012 |
Galvin J. Physician intention to screen for dementia Alzheimers & Dementia. 8: 126. DOI: 10.1016/J.Jalz.2012.05.331 |
0.339 |
|
| 2012 |
Galvin J, Roe C, Morris J. The AD8 dementia screening test detects mild cognitive impairment Alzheimers & Dementia. 8: 483. DOI: 10.1016/J.Jalz.2012.05.1307 |
0.428 |
|
| 2012 |
Johnson D, Galvin J, Storandt M. P3-080: Mild cognitive impairment in Parkinson's disease dementia Alzheimer's & Dementia. 8: P480-P481. DOI: 10.1016/J.Jalz.2012.05.1299 |
0.439 |
|
| 2011 |
Biagioni MC, Galvin JE. Using biomarkers to improve detection of Alzheimer's disease. Neurodegenerative Disease Management. 1: 127-139. PMID 22076127 DOI: 10.2217/Nmt.11.11 |
0.405 |
|
| 2011 |
Karantzoulis S, Galvin JE. Distinguishing Alzheimer's disease from other major forms of dementia. Expert Review of Neurotherapeutics. 11: 1579-91. PMID 22014137 DOI: 10.1586/Ern.11.155 |
0.465 |
|
| 2011 |
van Laar T, De Deyn PP, Aarsland D, Barone P, Galvin JE. Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data. Cns Neuroscience & Therapeutics. 17: 428-41. PMID 21951368 DOI: 10.1111/J.1755-5949.2010.00166.X |
0.426 |
|
| 2011 |
Correia CC, Lima F, Junqueira F, Campos MS, Bastos O, Petribú K, Laks J, Galvin JE. AD8-Brazil: cross-cultural validation of the ascertaining dementia interview in Portuguese. Journal of Alzheimer's Disease : Jad. 27: 177-85. PMID 21799253 DOI: 10.3233/Jad-2011-100915 |
0.429 |
|
| 2011 |
Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 77: 556-63. PMID 21795660 DOI: 10.1212/Wnl.0B013E318228Bf11 |
0.388 |
|
| 2011 |
Galvin JE, Meuser TM, Boise L, Connell CM. Internet-Based Dementia Resources: Physician Attitudes and Practices. Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society. 30: 513-523. PMID 21769164 DOI: 10.1177/0733464810363894 |
0.355 |
|
| 2011 |
Galvin JE, Price JL, Yan Z, Morris JC, Sheline YI. Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease. Neurology. 76: 1797-803. PMID 21525427 DOI: 10.1016/J.Jalz.2011.09.147 |
0.418 |
|
| 2011 |
Carpenter CR, Bassett ER, Fischer GM, Shirshekan J, Galvin JE, Morris JC. Four sensitive screening tools to detect cognitive dysfunction in geriatric emergency department patients: brief Alzheimer's Screen, Short Blessed Test, Ottawa 3DY, and the caregiver-completed AD8. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 18: 374-84. PMID 21496140 DOI: 10.1111/J.1553-2712.2011.01040.X |
0.405 |
|
| 2011 |
Yang YH, Galvin JE, Morris JC, Lai CL, Chou MC, Liu CK. Application of AD8 questionnaire to screen very mild dementia in Taiwanese. American Journal of Alzheimer's Disease and Other Dementias. 26: 134-8. PMID 21415088 DOI: 10.1177/1533317510397330 |
0.449 |
|
| 2011 |
Johnson DK, Galvin JE. Longitudinal changes in cognition in Parkinson's disease with and without dementia. Dementia and Geriatric Cognitive Disorders. 31: 98-108. PMID 21242691 DOI: 10.1159/000323570 |
0.4 |
|
| 2011 |
Galvin JE. Dementia screening, biomarkers and protein misfolding: Implications for public health and diagnosis. Prion. 5: 16-21. PMID 21164279 DOI: 10.4161/Pri.5.1.14439 |
0.409 |
|
| 2011 |
Leggett AN, Zarit S, Taylor A, Galvin JE. Stress and burden among caregivers of patients with Lewy body dementia. The Gerontologist. 51: 76-85. PMID 20667944 DOI: 10.1093/Geront/Gnq055 |
0.393 |
|
| 2011 |
Csernansky J, Wang L, Mehta N, Karagodin I, Beg MF, Morris J, Galvin J. P2-193: Treatment effects on hippocampal degeneration in dementia of the Alzheimer type Alzheimer's & Dementia. 7: S374-S375. DOI: 10.1016/J.Jalz.2011.05.1078 |
0.386 |
|
| 2011 |
Wilkins C, Roe C, Morris J, Galvin J. Mild physical impairment predicts diagnosis of dementia of the Alzheimer type Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1059 |
0.413 |
|
| 2010 |
Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. Jama. 304: 1903-11. PMID 21045096 DOI: 10.1001/Jama.2010.1510 |
0.368 |
|
| 2010 |
Galvin JE, Fagan AM, Holtzman DM, Mintun MA, Morris JC. Relationship of dementia screening tests with biomarkers of Alzheimer's disease. Brain : a Journal of Neurology. 133: 3290-300. PMID 20823087 DOI: 10.1093/Brain/Awq204 |
0.443 |
|
| 2010 |
Galvin JE, Kuntemeier B, Al-Hammadi N, Germino J, Murphy-White M, McGillick J. "Dementia-friendly hospitals: care not crisis": an educational program designed to improve the care of the hospitalized patient with dementia. Alzheimer Disease and Associated Disorders. 24: 372-9. PMID 20625267 DOI: 10.1097/Wad.0B013E3181E9F829 |
0.329 |
|
| 2010 |
Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH. Lewy body dementia: caregiver burden and unmet needs. Alzheimer Disease and Associated Disorders. 24: 177-81. PMID 20505434 DOI: 10.1097/Wad.0B013E3181C72B5D |
0.402 |
|
| 2010 |
Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH. Lewy body dementia: the caregiver experience of clinical care. Parkinsonism & Related Disorders. 16: 388-92. PMID 20434939 DOI: 10.1016/J.Parkreldis.2010.03.007 |
0.412 |
|
| 2010 |
Tarawneh R, Galvin JE. Potential future neuroprotective therapies for neurodegenerative disorders and stroke. Clinics in Geriatric Medicine. 26: 125-47. PMID 20176298 DOI: 10.1016/J.Cger.2009.12.003 |
0.323 |
|
| 2010 |
Escandon A, Al-Hammadi N, Galvin JE. Effect of cognitive fluctuation on neuropsychological performance in aging and dementia. Neurology. 74: 210-7. PMID 20083796 DOI: 10.1212/Wnl.0B013E3181Ca017D |
0.445 |
|
| 2010 |
Wang L, Harms MP, Staggs JM, Xiong C, Morris JC, Csernansky JG, Galvin JE. Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease. Archives of Neurology. 67: 99-106. PMID 20065136 DOI: 10.1001/Archneurol.2009.292 |
0.306 |
|
| 2010 |
Galvin JE, Fagan AM, Holtzman DM, Storandt M, Mintun MA, Morris JC. IC-P-007: Correlation of the AD8: an Informant-Based Dementia Screening Tool with Amyloid Imaging and CSF Biomarkers of Alzheimer Disease Alzheimer's & Dementia. 6: S8-S9. DOI: 10.1016/J.Jalz.2010.05.022 |
0.402 |
|
| 2009 |
Johnson DK, Storandt M, Morris JC, Galvin JE. Longitudinal study of the transition from healthy aging to Alzheimer disease. Archives of Neurology. 66: 1254-9. PMID 19822781 DOI: 10.1001/Archneurol.2009.158 |
0.422 |
|
| 2009 |
Norton JB, Cairns NJ, Chakraverty S, Wang J, Levitch D, Galvin JE, Goate A. Presenilin1 G217R mutation linked to Alzheimer disease with cotton wool plaques. Neurology. 73: 480-2. PMID 19667325 DOI: 10.1212/Wnl.0B013E3181B163Ba |
0.319 |
|
| 2009 |
Galvin JE, Meuser TM, Boise L, Connell CM. Predictors of physician referral for patient recruitment to Alzheimer disease clinical trials. Alzheimer Disease and Associated Disorders. 23: 352-6. PMID 19561438 DOI: 10.1097/Wad.0B013E31819E0Cac |
0.382 |
|
| 2009 |
Galvin JE. When a tremor is not just a tremor: cognitive and functional decline in essential tremor, a more complex disorder than we thought. Journal of the American Medical Directors Association. 10: 218-20. PMID 19426934 DOI: 10.1016/J.Jamda.2009.02.005 |
0.412 |
|
| 2009 |
Galvin JE, Meuser TM, Coats MA, Bakal DA, Morris JC. The "portable" CDR: translating the clinical dementia rating interview into a PDA format. Alzheimer Disease and Associated Disorders. 23: 44-9. PMID 18695592 DOI: 10.1097/Wad.0B013E31817634A0 |
0.355 |
|
| 2008 |
Johnson DK, Storandt M, Morris JC, Langford ZD, Galvin JE. Cognitive profiles in dementia: Alzheimer disease vs healthy brain aging. Neurology. 71: 1783-9. PMID 19029518 DOI: 10.1212/01.Wnl.0000335972.35970.70 |
0.476 |
|
| 2008 |
Galvin JE, Fu Q, Nguyen JT, Glasheen C, Scharff DP. Psychosocial determinants of intention to screen for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 353-60. PMID 18790462 DOI: 10.1016/J.Jalz.2007.09.005 |
0.368 |
|
| 2008 |
Fleisher AS, Raman R, Siemers ER, Becerra L, Clark CM, Dean RA, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Sherzai A, Sowell BB, Aisen PS, Thal LJ. Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Archives of Neurology. 65: 1031-8. PMID 18695053 DOI: 10.1001/Archneur.65.8.1031 |
0.354 |
|
| 2008 |
Galvin JE, Cornblatt B, Newhouse P, Ancoli-Israel S, Wesnes K, Williamson D, Zhu Y, Sorra K, Amatniek J. Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil. Alzheimer Disease and Associated Disorders. 22: 30-8. PMID 18317244 DOI: 10.1097/Wad.0B013E3181630B81 |
0.375 |
|
| 2008 |
Galvin JE, Meuser TM, Boise L, Connell CM. P2-273: Determinants of physician referrals to participate in Alzheimer's disease clinical trials Alzheimer's & Dementia. 4: T451-T452. DOI: 10.1016/J.Jalz.2008.05.1349 |
0.354 |
|
| 2008 |
Galvin JE, Fu Q, Scharff DP. P2-246: Assessing the quality of life-Alzheimer's disease scale in a community sample of nondemented older adults Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1321 |
0.318 |
|
| 2007 |
Tarawneh R, Galvin JE. Distinguishing Lewy body dementias from Alzheimer's disease. Expert Review of Neurotherapeutics. 7: 1499-516. PMID 17997699 DOI: 10.1586/14737175.7.11.1499 |
0.474 |
|
| 2007 |
Galvin JE. Pass the grain; spare the brain. Neurology. 69: 1072-3. PMID 17846407 DOI: 10.1212/01.Wnl.0000275542.03820.B1 |
0.397 |
|
| 2007 |
Galvin JE, Malcom H, Johnson D, Morris JC. Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease. Neurology. 68: 1895-901. PMID 17536045 DOI: 10.1212/01.Wnl.0000263131.80945.Ad |
0.446 |
|
| 2007 |
Galvin JE, Roe CM, Coats MA, Morris JC. Patient's rating of cognitive ability: using the AD8, a brief informant interview, as a self-rating tool to detect dementia. Archives of Neurology. 64: 725-30. PMID 17502472 DOI: 10.1001/Archneur.64.5.725 |
0.393 |
|
| 2007 |
Galvin JE, Roe CM, Morris JC. Evaluation of cognitive impairment in older adults: combining brief informant and performance measures. Archives of Neurology. 64: 718-24. PMID 17502471 DOI: 10.1001/Archneur.64.5.718 |
0.399 |
|
| 2007 |
Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 68: 812-9. PMID 17353469 DOI: 10.1212/01.Wnl.0000256715.13907.D3 |
0.39 |
|
| 2007 |
Galvin JE, Fu Q, Nguyen JT, Glasheen C, Scharff DP. P-006: Psychosocial determinants of intention to screen for Alzheimer disease: A population-based study Alzheimer's & Dementia. 3: S97-S97. DOI: 10.1016/J.Jalz.2007.04.222 |
0.332 |
|
| 2006 |
Galvin JE, Roe CM, Xiong C, Morris JC. Validity and reliability of the AD8 informant interview in dementia. Neurology. 67: 1942-8. PMID 17159098 DOI: 10.1212/01.Wnl.0000247042.15547.Eb |
0.395 |
|
| 2006 |
Williams MM, Xiong C, Morris JC, Galvin JE. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology. 67: 1935-41. PMID 17159097 DOI: 10.1212/01.Wnl.0000247041.63081.98 |
0.452 |
|
| 2006 |
Galvin JE. Cognitive change in Parkinson disease. Alzheimer Disease and Associated Disorders. 20: 302-10. PMID 17132978 DOI: 10.1097/01.Wad.0000213858.27731.F8 |
0.42 |
|
| 2006 |
Galvin JE, Pollack J, Morris JC. Clinical phenotype of Parkinson disease dementia. Neurology. 67: 1605-11. PMID 17101891 DOI: 10.1212/01.Wnl.0000242630.52203.8F |
0.47 |
|
| 2006 |
Galvin JE, Palamand D, Strider J, Milone M, Pestronk A. The muscle protein dysferlin accumulates in the Alzheimer brain. Acta Neuropathologica. 112: 665-71. PMID 17024495 DOI: 10.1007/S00401-006-0147-8 |
0.338 |
|
| 2006 |
Galvin JE, Scharff DP, Glasheen C, Fu Q. Development of a population-based questionnaire to explore psychosocial determinants of screening for memory loss and Alzheimer Disease. Alzheimer Disease and Associated Disorders. 20: 182-91. PMID 16917189 DOI: 10.1097/00002093-200607000-00010 |
0.397 |
|
| 2006 |
Siemers ER, Quinn JF, Kaye J, Farlow MR, Porsteinsson A, Tariot P, Zoulnouni P, Galvin JE, Holtzman DM, Knopman DS, Satterwhite J, Gonzales C, Dean RA, May PC. Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease. Neurology. 66: 602-4. PMID 16505324 DOI: 10.1212/01.Wnl.0000198762.41312.E1 |
0.317 |
|
| 2006 |
Leverenz JB, Berman S, Galasko DR, Bekris LM, Galvin JE, Goldman J, Irwin D, Kaufer D, Lippa C, Litvan I, Long A, Lopez OL, Tsuang D, Zabetian CP. P3-214: DEMENTIA WITH LEWY BODIES CONSORTIUM: METHODOLOGY AND INITIAL SUBJECT CHARACTERISTICS Alzheimer's & Dementia. 14: P1152-P1153. DOI: 10.1016/J.Jalz.2018.06.1573 |
0.349 |
|
| 2006 |
Galvin JE, Roe CM, Coats MA, Morris JC. P2-094: The AD8 as a self-rating tool of dementia and depression Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.931 |
0.338 |
|
| 2006 |
Galvin JE, Johnson DK, Morris JC. O1-05-02 Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.053 |
0.47 |
|
| 2005 |
Csernansky JG, Wang L, Miller JP, Galvin JE, Morris JC. Neuroanatomical predictors of response to donepezil therapy in patients with dementia. Archives of Neurology. 62: 1718-22. PMID 16286546 DOI: 10.1001/Archneur.62.11.1718 |
0.341 |
|
| 2005 |
Johnson DK, Morris JC, Galvin JE. Verbal and visuospatial deficits in dementia with Lewy bodies. Neurology. 65: 1232-8. PMID 16247050 DOI: 10.1212/01.Wnl.0000180964.60708.C2 |
0.467 |
|
| 2005 |
Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, Miller JP, Storandt M, Morris JC. The AD8: a brief informant interview to detect dementia. Neurology. 65: 559-64. PMID 16116116 DOI: 10.1212/01.Wnl.0000172958.95282.2A |
0.444 |
|
| 2005 |
Galvin JE, Powlishta KK, Wilkins K, McKeel DW, Xiong C, Grant E, Storandt M, Morris JC. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Archives of Neurology. 62: 758-65. PMID 15883263 DOI: 10.1001/Archneur.62.5.758 |
0.496 |
|
| 2005 |
Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DW. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology. 64: 1397-403. PMID 15851730 DOI: 10.1212/01.Wnl.0000158423.05224.7F |
0.408 |
|
| 2004 |
Galvin JE. Neurodegenerative diseases: pathology and the advantage of single-cell profiling. Neurochemical Research. 29: 1041-51. PMID 15176462 DOI: 10.1023/B:Nere.0000023592.53769.4D |
0.32 |
|
| 2004 |
Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DW. P3-173 Pathological correlates of the substantia nigra in Alzheimer's disease with extrapyramidal signs Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81325-3 |
0.375 |
|
| 2004 |
Galvin JE, Johnson DK. P1-118 Visuospatial and psychomotor deficits in Lewy Body Dementia: improving antemortem diagnosis Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80432-9 |
0.377 |
|
| 2004 |
Galvin JE, Palamand D, Milone M, Pestronk A. O1-01-01 Dysferlin in the Alzheimer's disease brain: another amyloid Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80028-9 |
0.336 |
|
| 2003 |
Galvin JE. Dementia with Lewy bodies. Archives of Neurology. 60: 1332-5. PMID 12975306 DOI: 10.1001/Archneur.60.9.1332 |
0.484 |
|
| 2002 |
Galvin JE, Lee SL, Perry A, Havlioglu N, McKeel DW, Morris JC. Familial dementia with Lewy bodies: clinicopathologic analysis of two kindreds. Neurology. 59: 1079-82. PMID 12370468 DOI: 10.1212/Wnl.59.7.1079 |
0.41 |
|
| 2001 |
Galvin JE, Lee VM, Trojanowski JQ. Synucleinopathies: clinical and pathological implications. Archives of Neurology. 58: 186-90. PMID 11176955 DOI: 10.1001/Archneur.58.2.186 |
0.303 |
|
| 2000 |
Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology. 54: 1916-21. PMID 10822429 DOI: 10.1212/Wnl.54.10.1916 |
0.38 |
|
| 1999 |
Galvin JE, Uryu K, Lee VM, Trojanowski JQ. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proceedings of the National Academy of Sciences of the United States of America. 96: 13450-5. PMID 10557341 DOI: 10.1073/Pnas.96.23.13450 |
0.301 |
|
| 1998 |
Ginsberg SD, Galvin JE, Chiu TS, Lee VM, Masliah E, Trojanowski JQ. RNA sequestration to pathological lesions of neurodegenerative diseases. Acta Neuropathologica. 96: 487-94. PMID 9829812 DOI: 10.1007/S004010050923 |
0.334 |
|
| 1997 |
Galvin JE, Lee VM, Baba M, Mann DM, Dickson DW, Yamaguchi H, Schmidt ML, Iwatsubo T, Trojanowski JQ. Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit. Annals of Neurology. 42: 595-603. PMID 9382471 DOI: 10.1002/Ana.410420410 |
0.368 |
|
| Show low-probability matches. |
